SCHEMBL19303136

SCHEMBL19303136

CC(CO)CCNC(=O)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.63
NPC1 O15118 5/20 0.60
RAB9A P51151 5/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
NAAA Q02083 1/20 0.53
GAA P10253 1/20 0.52
KCNA5 P22460 1/20 0.51
HPGD P15428 2/20 0.50
PRSS1 P07477 1/20 0.50
CTSG P08311 1/20 0.50
CTRB1 P17538 1/20 0.50
CMA1 P23946 1/20 0.50
RECQL P46063 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27467294 0.89 EPHX2 (0.61) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL10099587 0.87 EPHX2 (0.63) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL496789 0.84 SMN1; SMN2 (0.81) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL10912509 0.83 NPC1 (0.57) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL27389698 0.81 EPHX2 (0.65) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL27790062 0.81 EPHX2 (0.65) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL8851563 0.81 EPHX2 (0.65) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL6204191 0.80 EPHX2 (0.63) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL10722901 0.80 EPHX2 (0.73) EPHX2NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL8053368 0.79 EPHX2 (0.54) EPHX2NPC1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017144393-A1 2-SUBSTITUTED 5-(PHENYL)-1,2-DIHYDRO-3H-3-BENZAZEPINE-3-CARBOXAMIDE DERIVATIVES AS BRD4 INHIBITORS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-08-31 WO disclosed